1. Home
  2. ALGS vs IZEA Comparison

ALGS vs IZEA Comparison

Compare ALGS & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGS
  • IZEA
  • Stock Information
  • Founded
  • ALGS 2018
  • IZEA 2006
  • Country
  • ALGS United States
  • IZEA United States
  • Employees
  • ALGS N/A
  • IZEA N/A
  • Industry
  • ALGS Biotechnology: Pharmaceutical Preparations
  • IZEA Advertising
  • Sector
  • ALGS Health Care
  • IZEA Consumer Discretionary
  • Exchange
  • ALGS Nasdaq
  • IZEA Nasdaq
  • Market Cap
  • ALGS 53.0M
  • IZEA 44.6M
  • IPO Year
  • ALGS 2020
  • IZEA N/A
  • Fundamental
  • Price
  • ALGS $9.13
  • IZEA $3.94
  • Analyst Decision
  • ALGS Strong Buy
  • IZEA
  • Analyst Count
  • ALGS 1
  • IZEA 0
  • Target Price
  • ALGS $70.00
  • IZEA N/A
  • AVG Volume (30 Days)
  • ALGS 84.2K
  • IZEA 96.0K
  • Earning Date
  • ALGS 08-05-2025
  • IZEA 08-13-2025
  • Dividend Yield
  • ALGS N/A
  • IZEA N/A
  • EPS Growth
  • ALGS N/A
  • IZEA N/A
  • EPS
  • ALGS N/A
  • IZEA N/A
  • Revenue
  • ALGS $3,270,000.00
  • IZEA $36,896,490.00
  • Revenue This Year
  • ALGS N/A
  • IZEA $16.46
  • Revenue Next Year
  • ALGS $51.55
  • IZEA $15.95
  • P/E Ratio
  • ALGS N/A
  • IZEA N/A
  • Revenue Growth
  • ALGS N/A
  • IZEA 7.17
  • 52 Week Low
  • ALGS $3.76
  • IZEA $1.68
  • 52 Week High
  • ALGS $46.80
  • IZEA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • ALGS 59.79
  • IZEA 75.24
  • Support Level
  • ALGS $8.18
  • IZEA $2.55
  • Resistance Level
  • ALGS $9.44
  • IZEA $4.10
  • Average True Range (ATR)
  • ALGS 0.71
  • IZEA 0.26
  • MACD
  • ALGS 0.01
  • IZEA 0.11
  • Stochastic Oscillator
  • ALGS 65.95
  • IZEA 84.34

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

Share on Social Networks: